Quadriga Biosciences, Inc

Jazz Pharmaceuticals is a specialty pharmaceutical company that specializes in the development and commercialization of neurological and psychiatric products. The company offers products of various brands that include Xyrem and Antizol. Its products are used as an antidote for ethylene glycol and methanol ingestion. Jazz Pharmaceuticals offers support and guidance on reimbursement to patients through its patient affairs area and is a provider of chronic, patient-administered products. The company provides patient assistance programs on Xyrem and Cystadane through the National Organization of Rare Disorders, a nonprofit organization that specializes in the identification, treatment and cure of orphan diseases. Jazz Pharmaceuticals is headquartered in Palo Alto, Calif.

Corcept Therapeutics is a pharmaceutical firm engaged in the development of drugs for the treatment of severe psychiatric and neurological diseases. The company s lead product candidate, Corlux, is in clinical trials for the treatment of the psychotic features of psychotic major depression. PMD is a disorder that affects nearly three million people in the United States annually. The U.S. Food and Drug Administration has granted fast-track status to Corcept Therapeutics program. The company is headquartered in Menlo Park, Calif.

Siolta Therapeutics, Inc. is a biotechnology company located in San Carlos, California, specializing in the human microbiome and its impact on health. The company focuses on the maternal-infant axis and is dedicated to advancing science in this critical area through innovative research and development. Situated within the MBC BioLabs, one of the Bay Area's leading life science incubators, Siolta Therapeutics is committed to attracting top talent to further its mission. The company is actively engaged in building a robust pipeline of therapeutic solutions aimed at improving health outcomes for infants and mothers. Generated from the website